Applied Therapeutics Inc (APLT)

$5.13

-0.18

(-3.39%)

Market is closed - opens 8 PM, 22 Feb 2024

Performance

  • $5.00
    $5.37
    $5.13
    downward going graph

    2.53%

    Downside

    Day's Volatility :6.89%

    Upside

    4.47%

    downward going graph
  • $0.76
    $6.00
    $5.13
    downward going graph

    85.24%

    Downside

    52 Weeks Volatility :87.38%

    Upside

    14.5%

    downward going graph

Returns

PeriodApplied Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
168.18%
11.8%
0.0%
6 Months
290.44%
8.6%
0.0%
1 Year
431.0%
11.4%
-6.3%
3 Years
-74.26%
26.9%
-22.0%

Highlights

Market Capitalization
415.5M
Book Value
- $0.14
Earnings Per Share (EPS)
-1.25
Wall Street Target Price
8.33
Profit Margin
0.0%
Operating Margin TTM
-586.3%
Return On Assets TTM
-76.69%
Return On Equity TTM
-682.16%
Revenue TTM
10.7M
Revenue Per Share TTM
0.15
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-62.5M
Diluted Eps TTM
-1.25
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.51
EPS Estimate Next Year
-0.96
EPS Estimate Current Quarter
-0.26
EPS Estimate Next Quarter
-0.26

Analyst Recommendation

Buy
    88%Buy
    11%Hold
    0
    0%Sell
Based on 9 Wall street analysts offering stock ratings for Applied Therapeutics Inc(by analysts ranked 0 to 5 stars)
Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 62.38%

Current $5.13
Target $8.33

Technicals Summary

Sell

Neutral

Buy

Applied Therapeutics Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Applied Therapeutics Inc
Applied Therapeutics Inc
93.09%
290.44%
431.0%
-74.26%
-74.26%
Moderna, Inc.
Moderna, Inc.
-12.75%
-21.69%
-45.66%
-45.42%
349.79%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
0.43%
12.14%
26.84%
105.58%
126.19%
Novo Nordisk A/s
Novo Nordisk A/s
15.13%
30.68%
70.32%
233.88%
389.13%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
-4.42%
19.93%
43.82%
95.68%
129.78%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Applied Therapeutics Inc
Applied Therapeutics Inc
NA
NA
NA
-1.51
-6.82
-0.77
NA
-0.14
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-12.5
-0.22
-0.07
NA
35.32
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
27.55
27.55
1.93
44.91
0.16
0.08
NA
242.47
Novo Nordisk A/s
Novo Nordisk A/s
45.26
45.26
4.51
3.29
0.88
0.23
0.01
23.9
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
30.4
30.4
0.57
16.74
0.23
0.13
NA
68.22
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Applied Therapeutics Inc
Applied Therapeutics Inc
Buy
$415.5M
-74.26%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$33.7B
349.79%
24.73
-38.0%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$105.2B
126.19%
27.55
30.14%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$541.4B
389.13%
45.26
36.03%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$109.1B
129.78%
30.4
36.68%

Institutional Holdings

  • Franklin Resources Inc

    9.09%
  • VR Adviser, LLC

    7.33%
  • Knoll Capital Management LP

    6.68%
  • Alyeska Investment Group, L.P.

    5.47%
  • Armistice Capital, LLC

    4.40%
  • FMR Inc

    3.42%

Corporate Announcements

  • Applied Therapeutics Inc Earnings

    Applied Therapeutics Inc’s price-to-earnings ratio stands at None

    Read More

Company Information

applied therapeutics, inc. is a hospital and health care company located in 3104 cherry palm dr, tampa, fl, united states.

Organization
Applied Therapeutics Inc
Employees
22
CEO
Dr. Shoshana Shendelman Ph.D.
Industry
Biotechnology

FAQs